J. A. Misplon

发表

Genetic control of immune responses to influenza A matrix 2 protein (M2).

S. Tompkins, J. A. Misplon, C. Lo, 2010, Vaccine.

Effect of an Adenovirus-Vectored Universal Influenza Virus Vaccine on Pulmonary Pathophysiology in a Mouse Model

W. Mitzner, S. Klein, S. Dhakal, 2021, Journal of Virology.

Antibody repertoire in the response to a protein antigen. Interrelated idiotypic families in the response to Ia.7.

J. A. Misplon, S. Epstein, L. Harvath, 1994, Journal of immunology.

Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice.

K. Subbarao, E. E. Max, J. A. Misplon, 1997, Journal of immunology.

Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies

J. A. Misplon, C. Lo, S. Epstein, 2022, Journal of virology.

Enhanced T-cell activation and differentiation in lymphocytes from transgenic mice expressing ubiquitination-resistant 2KR LAT molecules

Y. Belkaid, L. Samelson, R. Kortum, 2015, Gene Therapy.

Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.

B. Murphy, M. Connors, J. A. Misplon, 1993, Journal of immunology.

Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells.

J. A. Misplon, C. Lo, S. Epstein, 2001, Journal of immunology.

Intranasal administration of adeno-associated virus type 12 (AAV12) leads to transduction of the nasal epithelia and can initiate transgene-specific immune response.

J. Chiorini, J. A. Misplon, C. Lo, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic

C. Viboud, M. Eichelberger, J. Gorski, 2017, Open forum infectious diseases.

Induction of antigen‐specific immunity with monoclonal anti‐idiotypic antibodies in vivo: differences in potency and comparison of immunochemical

J. A. Misplon, S. Epstein, L. J. Rubinstein, 1989, European journal of immunology.

Age Dependence of Immunity Induced by a Candidate Universal Influenza Vaccine in Mice

J. A. Misplon, C. Lo, S. Epstein, 2016, PloS one.

Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies.

W. Kong, T. Tumpey, C. Pappas, 2008, Vaccine.

DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

K. Subbarao, T. Tumpey, J. Katz, 2002, Emerging infectious diseases.

The effect of respiratory viruses on immunogenicity and protection induced by a candidate universal influenza vaccine in mice

J. A. Misplon, C. Lo, S. Epstein, 2019, PloS one.

Isolation and partial characterization of Fix− mutants from Rhizobium strain 32H1

J. A. Misplon, P. Bishop, 1983, Plant and Soil.

Cold-Adapted Influenza and Recombinant Adenovirus Vaccines Induce Cross-Protective Immunity against pH1N1 Challenge in Mice

Mark R. Soboleski, D. Pérez, Jianqiang Ye, 2011, PloS one.

Reduction of influenza virus transmission from mice immunized against conserved viral antigens is influenced by route of immunization and choice of vaccine antigen.

J. A. Misplon, C. Lo, S. Epstein, 2018, Vaccine.

Mucosal Immunization with a Candidate Universal Influenza Vaccine Reduces Virus Transmission in a Mouse Model

J. A. Misplon, C. Lo, S. Epstein, 2014, Journal of Virology.

Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses.

Mark R. Soboleski, T. Tumpey, C. Pappas, 2009, Vaccine.

Mechanism of protective immunity against influenza virus infection in mice without antibodies.

J. Bennink, J. A. Misplon, C. Lo, 1998, Journal of immunology.

Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice.

Z. Ye, J. A. Misplon, C. Lo, 2021, Vaccine.

Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses

Mark R. Soboleski, T. Tumpey, C. Pappas, 2010, PloS one.

Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

G. Nabel, W. Kong, T. Tumpey, 2005, Vaccine.

Conventional influenza vaccines influence the performance of a universal influenza vaccine in mice.

J. A. Misplon, C. Lo, S. Epstein, 2017, Vaccine.

Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo Pan paniscus

R. Cortese, A. Nicosia, Mark R. Soboleski, 2013, PloS one.

Matrix Protein 2 Vaccination and Protection against Influenza Viruses, Including Subtype H5N1

T. Tumpey, S. Tompkins, Z. Ye, 2007, Emerging infectious diseases.

Heterosubtypic Immunity to Influenza A Virus in Mice Lacking IgA, All Ig, NKT Cells, or γδ T Cells1

J. A. Misplon, C. Lo, S. Epstein, 2001, The Journal of Immunology.

Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge.

J. Bennink, K. Subbarao, J. A. Misplon, 2000, International immunology.

DNA Vaccine Expressing Conserved Influenza Virus Proteins Protective Against H5N1 Challenge Infection in Mice

K. Subbarao, T. Tumpey, J. Katz, 2002, Emerging Infectious Diseases.

Intranasal administration of adeno-associated virus type 12 (AAV12) leads to transduction of the nasal epithelia and can initiate transgene-specific immune response.

J. Chiorini, J. A. Misplon, C. Lo, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.